The FDA approves Aletta, a robotic device for autonomous blood draws, addressing phlebotomist shortages while ensuring patient safety.

One phlebotomist can oversee up to three Aletta units at once, which the FDA says may help address a shortage of trained blood draw technicians

The FDA approves Aletta, a robotic device for autonomous blood draws, addressing phlebotomist shortages while ensuring patient safety.